Monitoring of impurity level of valsartan and hydrochlorothiazide employing an RP-HPLC gradient mode

Journal of Liquid Chromatography and Related Technologies

Volumn 30, Issue 19, 2007, Pages 2879-2890

  Ivanović, Darko ^a   Malenović, Andelija ^a   Jančić, Biljana ^a   Medenica, Mirjana ^a   Mašković, Marija ^b  

^a Department of Physical Chemistry   (Yugoslavia)

^b Medicines and Medical Devices Agency of Serbia

Author keywords

High performance liquid chromatography; Hydrochlorothiazide; Impurities; Validation; Valsartan

Indexed keywords

BLOOD PRESSURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMPURITIES; PARAMETER ESTIMATION; PH EFFECTS; SEPARATION;

HYDROCHLOROTHIAZIDE; MONOTHERAPY; VALSARTAN;

NITROGEN COMPOUNDS;

ACETONITRILE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; PHOSPHORIC ACID; VALSARTAN; WATER;

ARTICLE; DRUG DETERMINATION; DRUG IMPURITY; DRUG MONITORING; ELUTION; LIPOPHILICITY; PHASE SEPARATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; TABLET FORMULATION;

EID: 34548306907     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070701588638     Document Type: Article

References (14)

1. Hillaert, S.; de Beer, T.R.M.; de Beer, J.O.; van den Bossche, W. Optimization and validation of a micellar electrokinetic chromatographic method for the analysis of several angiotensin-II-receptor antagonists. J. Chromatogr. A 2003, 984 (1), 135-146.
2. Hillaert, S.; van den Bossche, W. Optimization and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonists. J. Chromatogr. A 2002, 979 (1-2), 323-333.
3. Hillaert, S.; van den Bossche, W. Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis. J. Pharm. Biomed. Anal. 2003, 31 (2), 329-339.
4. Erk, N. Spectrophotometric analysis of valsartan and hydrochlorothiazide. Anal. Lett. 2002, 35 (2), 283-302.
5. Tatar, S.; Saglik, S. Comparison of UV- and second derivative- spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation. J. Pharm. Biomed. Anal. 2002, 30 (2), 371-375.
6. Satana, E.; Altinay, S.; Goger, N.G.; Ozkan, S.A.; Senturk, Z. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and LC. J. Pharm. Biomed. Anal. 2001, 25 (5-6), 1009-1013.
7. Dinc, E.; Uslu, B.; Ozkan, S.A. Spectral resolution of a binary mixture containing valsartan and hydrochlorothiazide in tablets by ratio spectra derivative and inverse least squares techniques. Anal. Lett. 2004, 37 (4), 679-693.
8. Cagigal, E.; Gonzales, L.; Alonso, R.M.; Jimenez, R.M. pKa determination of angiotensin-II-receptor antagonists by spectrofluorimetry. J. Pharm. Biomed. Anal. 2001, 26 (3), 477-486.
9. Carlucci, G.; di Carlo, V.; Mazzeo, P. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by high-performance liquid chromatography. Anal. Lett. 2000, 33 (12), 2491-2500.
10. Macek, J.; Klima, J.; Ptacek, P. Rapid determination of valsartan in human plasma by protein precipitation and high performance liquid chromatography. J. Chrom. B 2006, 832 (1), 169-172.
11. Daneshtalab, N.; Lewanczuk, R.Z.; Jamali, F. High-performance liquid chromatographic analysis of angiotensin-II-receptor antagonist valsartan using a liquid extraction method. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2002, 766 (2), 345-349.
12. Gonzales, L.; Lopez, J.A.; Alonso, R.M.; Jimenez, R.M. Fast screening method for the determination of angiotensin-II-receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr. A. 2002, 949 (1-2), 49-60.
13. Gonzales, L.; Alonso, R.M.; Jimenez, R.M. High-performance liquid-chromatographic method for screening angiotensin-II-receptor antagonists in human urine. Chromatographia. 2000, 52 (11-12), 735-740.
14. Cagigal, E.; Gonzales, L.; Alonso, R.M.; Jimenez, R.M. Experimental design methodologies to optimise the spectrofluorimetric determination of losartan and valsartan in human urine. Talanta. 2001, 54 (6), 1121-1133.